These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27725811)

  • 1. Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases.
    Górski A; Międzybrodzki R; Weber-Dąbrowska B; Fortuna W; Letkiewicz S; Rogóż P; Jończyk-Matysiak E; Dąbrowska K; Majewska J; Borysowski J
    Front Microbiol; 2016; 7():1515. PubMed ID: 27725811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections.
    Patey O; McCallin S; Mazure H; Liddle M; Smithyman A; Dublanchet A
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30597868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current State of Compassionate Phage Therapy.
    McCallin S; Sacher JC; Zheng J; Chan BK
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31013833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
    Furfaro LL; Payne MS; Chang BJ
    Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growing Trend of Fighting Infections in Aquaculture Environment-Opportunities and Challenges of Phage Therapy.
    Kowalska JD; Kazimierczak J; Sowińska PM; Wójcik EA; Siwicki AK; Dastych J
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32512805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and Pitfalls of Bacteriophage Therapy in Critical Care: A Concise Definitive Review.
    Valente L; Prazak J; Que YA; Cameron DR
    Crit Care Explor; 2021 Mar; 3(3):e0351. PubMed ID: 33786430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing Countries.
    Khalid A; Lin RCY; Iredell JR
    Front Microbiol; 2020; 11():599906. PubMed ID: 33643225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
    Hesse S; Adhya S
    Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Therapy in the Postantibiotic Era.
    Gordillo Altamirano FL; Barr JJ
    Clin Microbiol Rev; 2019 Apr; 32(2):. PubMed ID: 30651225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections.
    Reuter M; Kruger DH
    Virus Genes; 2020 Apr; 56(2):136-149. PubMed ID: 32036540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.
    Oechslin F
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29966329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
    Rohde C; Wittmann J; Kutter E
    Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an
    Rouse MD; Stanbro J; Roman JA; Lipinski MA; Jacobs A; Biswas B; Regeimbal J; Henry M; Stockelman MG; Simons MP
    Front Microbiol; 2020; 11():414. PubMed ID: 32256472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.